RQ BIOTECHNOLOGY LIMITED
Company number 13293828 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
-£904,079
Balance sheet as at 2022-03-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2021-03-26
- Employees
- 1 (2022 accounts)
- Registered office
- Scale Space, 58 Wood Lane, London, United Kingdom, W12 7RZ
- Postcode
- W12 7RZ
- Capital
- 1 GBP
- Accounts category
- Full
Accounts
- Last made up to
- 2026-03-31
- Next due by
- 2027-12-31
- Financial year end
- 31 March
Confirmation statement
- Last statement dated
- 2026-03-25
- Next due by
- 2027-04-08
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 4 current · 2 resigned
Group structure
Controlled by RQ BIOTECHNOLOGY HOLDINGS LIMITED — since 2024-04-08
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Contact details
- Website
- rqbiotechnology.com
RQ Bio develops long-acting monoclonal antibodies for seasonal influenza, offering immediate, potent, and lasting protection against severe disease.
Competitors London
This company ranks 134 among research and experimental development on biotechnology in London.